Kronox Lab Sciences Granted SEBI Approval to Initiate IPO

Speciality chemicals manufacturer Kronox Lab Sciences is set to enter the public market, having received approval from the Securities and Exchange Board of India (Sebi) for its Initial Public Offering (IPO). This move marks a significant milestone for the Vadodara-based company, known for its high-purity specialty fine chemicals widely used across various industries including pharmaceuticals, biotech, and agrochemicals. The IPO consists of an offer for sale (OFS) of 96 lakh equity shares by its promoters—Jogindersingh Jaswal, Ketan Ramani, and Pritesh Ramani, representing up to 26% of the company's paid-up equity share capital.

Representative image

The draft red herring prospectus (DRHP) filed with Sebi in January this year outlined the company's plans, with Sebi's observations received on April 12, effectively green-lighting the public issue. Kronox Lab Sciences boasts a diverse product portfolio with over 120 products in various stages of research and development. Its manufacturing prowess is supported by three facilities and a Research, Development, and Testing (RDT) laboratory located in Vadodara, Gujarat. Furthermore, the company is expanding its manufacturing capabilities with new land acquired at Dahej, Gujarat.

With a strong export presence in over 20 countries, including major markets like the USA, the UK, Mexico, Australia, and Egypt, Kronox Lab Sciences has established itself as a key player in the specialty chemicals industry. The company's equity shares are proposed to be listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE), with Pantomath Capital Advisors Private Ltd serving as the sole book-running lead manager for the IPO.

This IPO not only signifies Kronox Lab Sciences' growth trajectory but also highlights its commitment to expanding its global footprint and enhancing its research and development capabilities. As the specialty chemicals sector continues to evolve, Kronox's strategic initiatives position it well to capitalize on emerging opportunities.